Please provide your email address to receive an email when new articles are posted on . CHICAGO — Valacyclovir can be beneficial for treating multiple episodes of keratitis or iritis in patients with ...
Low-dose suppressive valacyclovir treatment of herpes zoster ophthalmicus (HZO) did not show significant benefits at 12 months but showed treatment superiority at 18 months and a reduction in the ...
CMV screening and valacyclovir use increased after a landmark French trial. Find out how practice patterns changed in ...
TORONTO -- The antiviral agent valacyclovir demonstrated no benefit in early Alzheimer's disease, the phase II VALAD trial showed. On the primary outcome of change in Alzheimer's Disease Assessment ...
Q. I had the flu in March 2020 and then came down with another infection. I think it was COVID-19, but there were no home tests at the time. Even though my case was no worse than the flu, it left me ...
Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir. HealthDay News — One year of valacyclovir is beneficial for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results